Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Johns Hopkins Singapore's Gilberto de Lima Lopes On Singapore’s Growing Importance For Phase I Trials: An Interview With PharmAsia News

This article was originally published in PharmAsia News

Executive Summary

Government investment in translational medicine and less-rigid regulations on foreign-approved drugs is starting to show returns for Singapore.

You may also be interested in...

Compounds Discovered In Asia Expected To Enter Clinic In Three Years, Pfizer Says

SINGAPORE - Pfizer expects to see drugs discovered and developed in Asia brought into the clinic in about three years, Pfizer's Pharma Therapeutics R&D Head Martin Mackay told local reporters April 7 during a press conference at the company's Clinical Research Unit at Raffles Hospital in Singapore

Sanofi, Merck Among Firms Collaborating With Asian Governments For Drug Development – World Vaccine Congress

A Thai-French joint venture will export Japanese encephalitis vaccines to 15 Asian countries starting in 2013.

Malaysia Gears Up To Launch Second VC Fund To Support Life Sciences – Biopharma Asia Conference

Malaysia readies to launch venture capital fund worth $100 million in the second quarter to support biopharma industry.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts